- Pasireotide is more effective than octreotide, alone or combined with everolimus on human meningioma
Pasireotide is more effective than octreotide, alone or combined with everolimus on human meningioma
Oncotarget (2017-09-15)
Thomas Graillon, David Romano, Céline Defilles, Christophe Lisbonis, Alexandru Saveanu, Dominique Figarella-Branger, Pierre-Hugues Roche, Stéphane Fuentes, Olivier Chinot, Henry Dufour, Anne Barlier
PMID28903425
ABSTRACT
Pasireotide is a somatostatin analog (SSA) that targets somatostatin receptor subtype 1 (SST1), SST2, SST3, and SST5 with a high affinity. Pasireotide has a better antisecretory effect in acromegaly, Cushing's disease, and neuroendocrine tumors than octreotide. In this study, we compared the effects of pasireotide to those of octreotide
MATERIALS
Product Number
Brand
Product Description